PODD Conference

Alex Guth, PhD, Managing Director & Partner, LEK Consulting

Mamata Majmundar, MD, CPE, FAAFP, Former CMO, EvryHealth

Gail Ryan, PharmD, Director of Pharmaceutical Transformation, Point32Health

Michael Sherman, MD, MBA, MS, Former CMO, Point32Health, Harvard Pilgrim Healthcare, Venture Partner, RA Capital

9:25AM - 9:45AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:45am to 10:40am

Morning Networking Break

9:45AM - 10:40AM

PODD Networking Break & Partnering

Graciously Hosted By:

Showing Events in 1 Track from 10:40am to 11:55pm

General Session Grand Ballroom, Concourse Level

10:40AM - 11:00AM

The Evolution of Technology and Key Challenges Being Addressed in Diabetes Care

Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize

11:00AM - 11:30AM

The Realities of Developing Self Administration of Subcutaneous Therapeutics

Monica Adams, PhD, MBA, Global Head , Packaging, Device, and Design Solutions, GSK

Scott Ariagno, VP, Engineering & Development Services, EdgeOne Medical

Advait Badkar, PhD, Executive Director- Drug Product Design and Development & Head of Nanoparticle Development, Biotherapeutics Pharmaceutical Sciences, Pfizer

Sujit Basu, PhD, Head, Pharmaceutical Development, Ionis Pharmaceuticals

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

11:30AM - 11:55PM

Industrialization of Dual Chamber Delivery Systems and Fill-Finish to Serve the Needs of Obesity and Diabetes Pipeline Therapies

John Merhige, Chief Commercial Officer, Credence MedSystems

Douglas Bryans, PhD, President and CEO, Bryllan LLC

Joan Melé, Chief Commercial Officer, Dara

Courtney Nicholas Sutton, Associate Director, Device Development, AstraZeneca

11:55AM - 12:40PM

PODD Annual Soapbox Presentations

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Hosted By:

Showing Events in 1 Track from 12:40pm to 01:55pm

Luncheon & Partnering Meetings

12:40PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 3 Tracks from 02:00pm to 03:20pm

Track 1: Biologic, Cell & Gene Delivery Grand Ballroom A, Concourse Level

Chaired by:

Aly Jackson, MS, MBA, Business Development, Genentech / Roche

Novel Cell Therapy: Advances in Targeting and Payload Delivery

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Luis Santos, PhD, Senior Director, Prime Medicine

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

Breakthrough Device for Oral Delivery of Biologics

Gil Cohen, PhD, VP Research & Development, Epitomee Medical

The Growing Impact of AI Approaches to Deliver Cell & Gene Therapy

Ester Caffarel-Salvador, PhD, Director, Strategic Innovation, Rare Diseases, Chiesi USA

Robert Amezquita, PhD, Principal Data Scientist, Computational Immunology, Research Data Science, mRNA Center of Excellence, Sanofi

Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company

Ketaki Deshmukh, PhD, Sr. Scientist, Non Viral Delivery, Novo Nordisk

Hicham Majd, PhD, Associate Director, Science & Technology, Novartis

Andre Watson, Chair & CEO, Ligandal

Track 2: Combination Devices Grand Ballroom B, Concourse Level

Chaired by:

Scott Gibson, Director, Systems Engineering, Combination Product Operations, Amgen

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Christian Jones, Chief Commercial Officer, Nanoform

Lindsey Crawford, PhD, Senior Principal Scientist, Pfizer

Dany Doucet, PhD, Director of the Early Engagement and Deviceability, GSK

E Guan, PhD, Head of Injection Systems, Takeda

Nicholas Schill, PhD, Senior Director, Product Development, Kymanox

Advanced Device Due-Diligence: Technical Reviews from Cradle to Grave

Tim Quigg, Development Director, Crux Product Design

Accelerating Evaluations of New Device Technologies for Complex Formulations

Josh Horvath, PhD, Senior Director, Device & Packaging Development, Genentech

Jason Durkin, VP of Supply Chain, Windgap Medical

Matthew Fordham, M.Eng, MBA, Deputy Head of Drug Delivery & Head of Client Management, Cambridge Design Partnership

Gabrielle Gehron, Technical and Scientific Expert, Datwyler Pharma Packaging USA Inc.

Sindhuja Kuchibhatla, Senior Manager, Device Technology & Innovation, GSK

Track 3: Excipients & Manufacturing Grand Ballroom D/E, Concourse Level

Chaired by:

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

2:00PM - 2:40PM

Improving Bioavailability and Stability Through Excipient Innovation

Monica Swinney, PhD, Senior Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences

Sreejit Menon, PhD, Head of Life Sciences R&D, North America, Croda

Edel Mullen, PhD, MBA, BSc, Director Drug Product Technologies, Amgen

Stephanie Reed, PhD, Director, Early Stage Formulation, Biopharmaceutical Development, AstraZeneca

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

2:40PM - 3:20PM

Designing and Developing Drug Delivery for LMICs

Justin M Wright, PhD, VP, Device, Packaging, and Sterile Process Development, Gilead Sciences

Niya Bowers, PhD, Senior Program Officer, Bill & Melinda Gates Foundation

Bo Kowalczyk, MBA, Chief Commercial Officer, ApiJect

Tycho Speaker, PhD, Senior Principal Research Scientist, Combination Product Development and Drug Delivery, AbbVie

Showing Events in 1 Track from 03:20pm to 03:35pm

Afternoon Networking Break

3:20PM - 3:35PM

Afternoon Networking Break

Showing Events in 3 Tracks from 03:35pm to 05:05pm

Track 1: Targeted & Long Acting Delivery Grand Ballroom A, Concourse Level

Chaired by:

Aly Jackson, MS, MBA, Business Development, Genentech / Roche

Sustained Release Innovations to Reduce Patient Burden

Stephen Buckley, PhD, VP, Advanced Drug Delivery, Novo Nordisk

Manish Gupta, PhD, Executive Director R&D, Drug Product Development - Steriles, GSK

Adam Mendelsohn, PhD, CEO, Vivani Medical

Bin Wu, PhD, Founder, Phosphorex

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

Lipa Shah, PhD, Director Science and Technology, Drug Development/ Pharmaceutical Development, Novartis Biomedical Research

Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca

Andy Lewis, PhD, Chief Scientific Officer, Quotient Sciences

Suman Luthra, PhD, Director | Discovery Pharmaceutical Sciences, Merck

New Approaches to Achieve Targeted Brain Delivery Without Increasing Toxicity

Alexander Josowitz, PhD, Senior Scientist, Formulations Development, Regeneron

Bill Loudon, MD, PhD, VP NeuroScience, Bionaut Labs

Darren Reid, PhD, Director, Process Development, Amgen

Lisa Shafer, PhD, Global Head of Product Development and Reg CMC, Medical Devices and Packaging, Biogen

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Track 2: Novel Devices Grand Ballroom B, Concourse Level

Chaired by:

Scott Gibson, Director, Systems Engineering, Combination Product Operations, Amgen

Translating Digital Health from the Clinic to Market Access and Commercial Success

Paul Upham, Head, Smart Devices, Genentech

Matthew Keiser, MS, Director, Core Team Leader & Industrialization Lead, EMD Serono

Vince Masciopinto, Customer Solutions Director, SHL Medical

Sarah Small, Director, Health Experience Development, Otsuka Precision Health

Lessons Learned in the Development and Introduction of Closed Loop Systems

Christopher Kovalchick, PhD, Director, Systems Engineering, Abbott Diabetes Care, Abbott

Henrik Bengtsson, E-MBA, Senior Innovation Lead (Director), Novo Nordisk

Louis DeRidder, PhD Candidate, Harvard Medical School and MIT

Ben Lane, MS, VP Product Development, Key Tech Inc.

Steven J. Russell, MD, PhD, Associate Professor of Medicine, Harvard Medical School, CMO, Beta Bionics

Biomaterial Implants to Reduce Patient Burden and Improve Adherence

Cameron Lee, PhD, Associate Director, Novartis Institutes for BioMedical Research

C Eric Elmquist, PhD, COO of R&D, Pendant Biosciences

Eileen Sadeghi, PhD, Senior Scientist II, AbbVie

Jaymin Shah, PhD, Senior Research Fellow and Head of Global Bioharmaceutics, Pharmaceutical Sciences Small Molecules, Pfizer

Milin Shah, PhD, Director, Biotech Ecosystem Development, Thermo Fisher Scientific

Track 3: Novel Modalities Grand Ballroom D/E, Concourse Level

Chaired by:

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

Advances in Pulmonary Delivery of Biologics

Michael Song, PhD, Director, Moderna

Alessandro Cavecchi, M.Sc., Head of Pharmaceutical Technology, Chiesi Farmaceutici S.p.A.

Philippe Rogueda, PhD, FRSC, CChem, CSci, Chief Business Officer, Merxin Ltd

Vaccine Delivery Innovations

Anthony Barry, PhD, Executive Director and ES&I Lead: Biotherapeutics, Technologies and Digital, Pfizer

John Lewis, PhD, CEO, Entos Pharmaceuticals

Namal Nawana, BEng, MMedSc, MBA, Executive Chairman & Founder, SatioRX

Derek O'Hagan, Senior Advisor Vaccines R&D, GSK

Focused Ultrasound Delivery in Clinical Trials and Beyond

Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, Novartis

Elisa Konofagou, PhD, Robert and Margaret Hariri Professor of Biomedical Engineering, Professor of Radiology (Physics) Department of Biomedical Engineering, Columbia University

Jérôme Marzinski, MBA, CEO, OxSonics

Chung-Hsin Wang, PhD, Founder, Trust Bio-sonics Inc.

Showing Events in 1 Track from 05:05pm to 05:10pm

PODD Conference Concludes

5:05PM - 5:10PM

PODD Conference Concludes

Showing Events in 1 Track from 07:20am to 08:30am

Morning General Session
Grand Ballroom, Concourse Level

7:20AM - 8:20AM

Partnering Meetings

8:20AM - 8:30AM

Co-Chairs' Opening Remarks

Co-Chairs:

Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

Aly Jackson, MS, MBA, Business Development, Genentech / Roche

Showing Events in 1 Track from 08:30am to 08:55am

Keynote Presentation
Grand Ballroom, Concourse Level

8:30AM - 8:55AM

Keynote Presentation: The Evolution of Delivery Approaches for In Vivo Gene Editing to Achieve Meaningful Clinical Impact

Keynote:

Laura Sepp-Lorenzino, PhD, Chief Scientific Officer, Intellia Therapeutics

Showing Events in 1 Track from 08:55am to 09:45am

Morning General Session
Grand Ballroom, Concourse Level

8:55AM - 9:25AM

Payer Perspectives on Drug Delivery

Alex Guth, PhD, Managing Director & Partner, LEK Consulting

Mamata Majmundar, MD, CPE, FAAFP, Former CMO, EvryHealth

Gail Ryan, PharmD, Director of Pharmaceutical Transformation, Point32Health

Michael Sherman, MD, MBA, MS, Former CMO, Point32Health, Harvard Pilgrim Healthcare, Venture Partner, RA Capital

9:25AM - 9:45AM

Drug Delivery Pipeline & Technologies, a Year in Review

Kurt Sedo, Vice President, PharmaCircle

Showing Events in 1 Track from 09:45am to 10:40am

Morning Networking Break

9:45AM - 10:40AM

PODD Networking Break & Partnering

Graciously Hosted By:

Showing Events in 1 Track from 10:40am to 11:55pm

General Session
Grand Ballroom, Concourse Level

10:40AM - 11:00AM

The Evolution of Technology and Key Challenges Being Addressed in Diabetes Care

Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize

11:00AM - 11:30AM

The Realities of Developing Self Administration of Subcutaneous Therapeutics

Monica Adams, PhD, MBA, Global Head , Packaging, Device, and Design Solutions, GSK

Scott Ariagno, VP, Engineering & Development Services, EdgeOne Medical

Advait Badkar, PhD, Executive Director- Drug Product Design and Development & Head of Nanoparticle Development, Biotherapeutics Pharmaceutical Sciences, Pfizer

Sujit Basu, PhD, Head, Pharmaceutical Development, Ionis Pharmaceuticals

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

11:30AM - 11:55PM

Industrialization of Dual Chamber Delivery Systems and Fill-Finish to Serve the Needs of Obesity and Diabetes Pipeline Therapies

John Merhige, Chief Commercial Officer, Credence MedSystems

Douglas Bryans, PhD, President and CEO, Bryllan LLC

Joan Melé, Chief Commercial Officer, Dara

Courtney Nicholas Sutton, Associate Director, Device Development, AstraZeneca

11:55AM - 12:40PM

PODD Annual Soapbox Presentations

Patrick Lim Soo, PhD, Associate Research Fellow, Pharmaceutical Research & Development, Pfizer

Hosted By:

Showing Events in 1 Track from 12:40pm to 01:55pm

Luncheon & Partnering Meetings

12:40PM - 1:55PM

Luncheon & Partnering Meetings

Showing Events in 3 Tracks from 02:00pm to 03:20pm

Track 1: Biologic, Cell & Gene Delivery
Grand Ballroom A, Concourse Level

Chaired by:

Aly Jackson, MS, MBA, Business Development, Genentech / Roche

Novel Cell Therapy: Advances in Targeting and Payload Delivery

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Luis Santos, PhD, Senior Director, Prime Medicine

Kanika Suri, PhD, Scientist, Drug Product Development, CMC, Takeda Pharmaceuticals

Breakthrough Device for Oral Delivery of Biologics

Gil Cohen, PhD, VP Research & Development, Epitomee Medical

The Growing Impact of AI Approaches to Deliver Cell & Gene Therapy

Ester Caffarel-Salvador, PhD, Director, Strategic Innovation, Rare Diseases, Chiesi USA

Robert Amezquita, PhD, Principal Data Scientist, Computational Immunology, Research Data Science, mRNA Center of Excellence, Sanofi

Sean Bedingfield, PhD, R&D Advisor - Genetic Medicine, Eli Lilly and Company

Ketaki Deshmukh, PhD, Sr. Scientist, Non Viral Delivery, Novo Nordisk

Hicham Majd, PhD, Associate Director, Science & Technology, Novartis

Andre Watson, Chair & CEO, Ligandal

Track 2: Combination Devices
Grand Ballroom B, Concourse Level

Chaired by:

Scott Gibson, Director, Systems Engineering, Combination Product Operations, Amgen

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

Christian Jones, Chief Commercial Officer, Nanoform

Lindsey Crawford, PhD, Senior Principal Scientist, Pfizer

Dany Doucet, PhD, Director of the Early Engagement and Deviceability, GSK

E Guan, PhD, Head of Injection Systems, Takeda

Nicholas Schill, PhD, Senior Director, Product Development, Kymanox

Advanced Device Due-Diligence: Technical Reviews from Cradle to Grave

Tim Quigg, Development Director, Crux Product Design

Accelerating Evaluations of New Device Technologies for Complex Formulations

Josh Horvath, PhD, Senior Director, Device & Packaging Development, Genentech

Jason Durkin, VP of Supply Chain, Windgap Medical

Matthew Fordham, M.Eng, MBA, Deputy Head of Drug Delivery & Head of Client Management, Cambridge Design Partnership

Gabrielle Gehron, Technical and Scientific Expert, Datwyler Pharma Packaging USA Inc.

Sindhuja Kuchibhatla, Senior Manager, Device Technology & Innovation, GSK

Track 3: Excipients & Manufacturing
Grand Ballroom D/E, Concourse Level

Chaired by:

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

2:00PM - 2:40PM

Improving Bioavailability and Stability Through Excipient Innovation

Monica Swinney, PhD, Senior Director, New Product Planning & Drug Delivery Innovation, Gilead Sciences

Sreejit Menon, PhD, Head of Life Sciences R&D, North America, Croda

Edel Mullen, PhD, MBA, BSc, Director Drug Product Technologies, Amgen

Stephanie Reed, PhD, Director, Early Stage Formulation, Biopharmaceutical Development, AstraZeneca

Liping Zhou, PhD, Senior Director, Advanced Drug Delivery, AstraZeneca

2:40PM - 3:20PM

Designing and Developing Drug Delivery for LMICs

Justin M Wright, PhD, VP, Device, Packaging, and Sterile Process Development, Gilead Sciences

Niya Bowers, PhD, Senior Program Officer, Bill & Melinda Gates Foundation

Bo Kowalczyk, MBA, Chief Commercial Officer, ApiJect

Tycho Speaker, PhD, Senior Principal Research Scientist, Combination Product Development and Drug Delivery, AbbVie

Showing Events in 1 Track from 03:20pm to 03:35pm

Afternoon Networking Break

3:20PM - 3:35PM

Afternoon Networking Break

Showing Events in 3 Tracks from 03:35pm to 05:05pm

Track 1: Targeted & Long Acting Delivery
Grand Ballroom A, Concourse Level

Chaired by:

Aly Jackson, MS, MBA, Business Development, Genentech / Roche

Sustained Release Innovations to Reduce Patient Burden

Stephen Buckley, PhD, VP, Advanced Drug Delivery, Novo Nordisk

Manish Gupta, PhD, Executive Director R&D, Drug Product Development - Steriles, GSK

Adam Mendelsohn, PhD, CEO, Vivani Medical

Bin Wu, PhD, Founder, Phosphorex

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

Lipa Shah, PhD, Director Science and Technology, Drug Development/ Pharmaceutical Development, Novartis Biomedical Research

Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca

Andy Lewis, PhD, Chief Scientific Officer, Quotient Sciences

Suman Luthra, PhD, Director | Discovery Pharmaceutical Sciences, Merck

New Approaches to Achieve Targeted Brain Delivery Without Increasing Toxicity

Alexander Josowitz, PhD, Senior Scientist, Formulations Development, Regeneron

Bill Loudon, MD, PhD, VP NeuroScience, Bionaut Labs

Darren Reid, PhD, Director, Process Development, Amgen

Lisa Shafer, PhD, Global Head of Product Development and Reg CMC, Medical Devices and Packaging, Biogen

Shankar Swaminathan, PhD, Associate Director, Drug Product Development, Astellas Institute for Regenerative Medicine, Astellas Pharma

Track 2: Novel Devices
Grand Ballroom B, Concourse Level

Chaired by:

Scott Gibson, Director, Systems Engineering, Combination Product Operations, Amgen

Translating Digital Health from the Clinic to Market Access and Commercial Success

Paul Upham, Head, Smart Devices, Genentech

Matthew Keiser, MS, Director, Core Team Leader & Industrialization Lead, EMD Serono

Vince Masciopinto, Customer Solutions Director, SHL Medical

Sarah Small, Director, Health Experience Development, Otsuka Precision Health

Lessons Learned in the Development and Introduction of Closed Loop Systems

Christopher Kovalchick, PhD, Director, Systems Engineering, Abbott Diabetes Care, Abbott

Henrik Bengtsson, E-MBA, Senior Innovation Lead (Director), Novo Nordisk

Louis DeRidder, PhD Candidate, Harvard Medical School and MIT

Ben Lane, MS, VP Product Development, Key Tech Inc.

Steven J. Russell, MD, PhD, Associate Professor of Medicine, Harvard Medical School, CMO, Beta Bionics

Biomaterial Implants to Reduce Patient Burden and Improve Adherence

Cameron Lee, PhD, Associate Director, Novartis Institutes for BioMedical Research

C Eric Elmquist, PhD, COO of R&D, Pendant Biosciences

Eileen Sadeghi, PhD, Senior Scientist II, AbbVie

Jaymin Shah, PhD, Senior Research Fellow and Head of Global Bioharmaceutics, Pharmaceutical Sciences Small Molecules, Pfizer

Milin Shah, PhD, Director, Biotech Ecosystem Development, Thermo Fisher Scientific

Track 3: Novel Modalities
Grand Ballroom D/E, Concourse Level

Chaired by:

Sherri Biondi, PhD, Executive Director and Head of Device Development, AstraZeneca

Advances in Pulmonary Delivery of Biologics

Michael Song, PhD, Director, Moderna

Alessandro Cavecchi, M.Sc., Head of Pharmaceutical Technology, Chiesi Farmaceutici S.p.A.

Philippe Rogueda, PhD, FRSC, CChem, CSci, Chief Business Officer, Merxin Ltd

Vaccine Delivery Innovations

Anthony Barry, PhD, Executive Director and ES&I Lead: Biotherapeutics, Technologies and Digital, Pfizer

John Lewis, PhD, CEO, Entos Pharmaceuticals

Namal Nawana, BEng, MMedSc, MBA, Executive Chairman & Founder, SatioRX

Derek O'Hagan, Senior Advisor Vaccines R&D, GSK

Focused Ultrasound Delivery in Clinical Trials and Beyond

Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, Novartis